ResearcherSecond Military Medical UniversityActive in the last 2 years

Ting Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9248-4361; OpenAlex author ID A5100427913. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

Discovery of CMNPD31124 as a novel marine-derived PKMYT1 inhibitor for pancreatic ductal adenocarcinoma therapy: computational and biological insights. First author DOI 10.3389/fphar.2025.1569765 ↗
GALNT5 functions as a suppressor of ferroptosis and a predictor of poor prognosis in pancreatic adenocarcinoma. Last author PMID 37970359 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Chaojie Huang · 1 shared paper, 2025 · strength 0.37
- Paper Discovery of CMNPD31124 as a novel marine-derived PKMYT1 inhibitor for pancreatic ductal adenocarcinoma therapy: comput… DOI 10.3389/fphar.2025.1569765 ↗
Yunyun Xu · 1 shared paper, 2025 · strength 0.37
- Paper Discovery of CMNPD31124 as a novel marine-derived PKMYT1 inhibitor for pancreatic ductal adenocarcinoma therapy: comput… DOI 10.3389/fphar.2025.1569765 ↗
Jiayi Yan · 1 shared paper, 2023 · strength 0.20
- Paper GALNT5 functions as a suppressor of ferroptosis and a predictor of poor prognosis in pancreatic adenocarcinoma. PMID 37970359 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.